Pilot Test of a Community-based Buprenorphine Treatment Intervention

Completed · Not applicable

Conditions studied: Opioid Dependence, Injection Drug Use

In brief

The main goal of this study is to pilot test the community-based buprenorphine treatment (CBBT) intervention, examining buprenorphine treatment initiation, opioid use, and HIV risk behaviors. Two groups of participants will be followed for 60 days, with 3 research visits. One group will be enrolled prior to the CBBT intervention (pre-intervention), and one group after the CBBT intervention (post-intervention). Data sources will include questionnaires, urine toxicology tests, and medical record data. Investigators hypothesize that compared to the participants in the pre-intervention group, participants in the post-intervention group will be more likely to initiate buprenorphine treatment, reduce opioid use, and reduce high-risk HIV risk behaviors.

Key facts

Study ID

NCT01761110

Run by

Albert Einstein College of Medicine

People needed

77

Starts

2012-12-01

Expected to finish

2014-02-01

Last updated by the study team

2018-04-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• at least 18 years old
• English or Spanish fluency
• ever injected drugs
• not receiving buprenorphine treatment (no prescribed buprenorphine in the previous 6 months)
• clients of our collaborating community-based organization
• interested in buprenorphine treatment

You may not qualify if…

• pregnant
• taking more than 60mg of methadone daily in the previous 30 days

Where it is running

• Washington Heights Corner Project — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.